Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Regen BioPharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
RGBP
Over the counter
2834
https://regenbiopharmainc.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Regen BioPharma Inc
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
- Apr 3rd, 2024 11:00 am
Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024
- Apr 2nd, 2024 1:30 pm
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
- Mar 6th, 2024 12:00 pm
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024
- Mar 5th, 2024 1:30 pm
Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now
- Feb 6th, 2024 12:00 pm
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024
- Feb 5th, 2024 12:00 pm
Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now
- Jan 9th, 2024 12:00 pm
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024
- Jan 8th, 2024 1:00 pm
Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
- Dec 6th, 2023 12:00 pm
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023
- Dec 5th, 2023 2:00 pm
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments
- Nov 16th, 2023 2:00 pm
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program
- Nov 14th, 2023 2:00 pm
Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now
- Oct 31st, 2023 11:00 am
Regen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023
- Oct 30th, 2023 1:30 pm
Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program
- Oct 25th, 2023 1:30 pm
Regen BioPharma, Inc. Expects Second Phase of Confirmatory Study Shortly
- Oct 18th, 2023 12:00 pm
Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032
- Oct 12th, 2023 1:00 pm
Regen BioPharma, Inc. Receives First Phase of Confirmatory Study
- Oct 10th, 2023 12:00 pm
Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.
- Oct 4th, 2023 1:25 pm
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on October 5, 2023
- Oct 3rd, 2023 7:52 pm
Scroll